Search Results
What to Expect with CAR T Cell Therapy and Bispecifics in Myeloma (2022) | Dr. Joshua Richter
What Are Bispecifics in Multiple Myeloma? (For Patients and Caregivers) | Dr. Joshua Richter
Emerging Bispecifics Myeloma Patients Should Know About | Dr. Joshua Richter | The Patient Story
T Cell Re-direction Therapy | Joshua Richter, MD | EHA 2022
How to optimize access to CAR-T cell therapies in multiple myeloma
Myeloma Research | CAR-T Cell & Bispecifics Study Updates
Bispecific Antibodies | Joshua Richter, MD | ASH 2022
CAR T Cell Therapy & Bispecifics: Cutting Edge Treatment in Myeloma | Dr. Joseph Mikhael
Could combinatorial CAR-T approaches lead to curative therapy for multiple myeloma?
What are CELMoDs in Multiple Myeloma (& When Will They Be Available?) | Dr. Joshua Richter
Joshua Richter, MD, Talks Results from LINKER-MM1 Study
Questions to Ask My Doctor about New Myeloma Treatments | Dr. Joshua Richter | The Patient Story
